Jiangsu Sinopep-Allsino Biopharmaceutical Co.,Ltd.’s Net Profit Rose 26% in First Quarter of 2023

Jiangsu Sinopep-Allsino Biopharmaceutical Co.,Ltd. (江苏诺泰澳赛诺生物制药股份有限公司) (688076.SH) reported a net profit of 18.9 million yuan in the first quarter of 2023, up 26% year-on-year.

Meanwhile, the company posted 208.1 million yuan in revenue, up 55% year-on-year.

At the end of the reporting period, it had 2.6 billion yuan in total assets and 648.7 million yuan in total liabilities, with a liability-to-asset ratio of 25%.